Effects of obesity on the association between long-term sleep apnea treatment and changes in interleukin-6 levels: the Icelandic Sleep Apnea Cohort.
To access publisher's full text version of this article click on the hyperlink at the bottom of the page The aim of this study was to evaluate changes in interleukin (IL)-6 and soluble IL-6 receptor levels in obstructive sleep apnea patients and assess the role of positive airway pressure treat...
Published in: | Journal of Sleep Research |
---|---|
Main Authors: | , , , , , , , |
Other Authors: | |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Blackwell Scientific Publications
2015
|
Subjects: | |
Online Access: | http://hdl.handle.net/2336/346790 https://doi.org/10.1111/jsr.12252 |
id |
ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/346790 |
---|---|
record_format |
openpolar |
spelling |
ftlandspitaliuni:oai:www.hirsla.lsh.is:2336/346790 2023-05-15T16:52:47+02:00 Effects of obesity on the association between long-term sleep apnea treatment and changes in interleukin-6 levels: the Icelandic Sleep Apnea Cohort. Arnardottir, Erna S Lim, Diane C Keenan, Brendan T Maislin, Greg Benediktsdottir, Bryndis Juliusson, Sigurdur Pack, Allan I Gislason, Thorarinn Department of Respiratory Medicine and Sleep, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Center for Sleep and Circadian Neurobiology, Division of Sleep Medicine/Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. 2015 http://hdl.handle.net/2336/346790 https://doi.org/10.1111/jsr.12252 en eng Blackwell Scientific Publications http://dx.doi.org/10.1111/jsr.12252 http://onlinelibrary.wiley.com/doi/10.1111/jsr.12252/epdf J Sleep Res 2015, 24 (2):148-59 1365-2869 25359691 doi:10.1111/jsr.12252 http://hdl.handle.net/2336/346790 Journal of sleep research Archived with thanks to Journal of sleep research National Consortium - Landsaðgangur Inflammation Obesity Sleep Apnea Obstructive Cytokine Receptor gp130 Biological Markers/analysis Body Mass Index Continuous Positive Airway Pressure/utilization* Female Follow-Up Studies Humans Iceland Interleukin-6/analysis Interleukin-6/metabolism* Male Middle Aged Patient Compliance/statistics & numerical data Receptors Interleukin-6/metabolism Article 2015 ftlandspitaliuni https://doi.org/10.1111/jsr.12252 2022-05-29T08:22:02Z To access publisher's full text version of this article click on the hyperlink at the bottom of the page The aim of this study was to evaluate changes in interleukin (IL)-6 and soluble IL-6 receptor levels in obstructive sleep apnea patients and assess the role of positive airway pressure treatment and obesity on these changes. A total of 309 newly diagnosed subjects with sleep apnea from the Icelandic Sleep Apnea Cohort were referred for treatment and reassessed at a 2-year follow-up. Full treatment was defined objectively as use ≥4 h day(-1) and ≥20 days month(-1) . At the 2-year follow-up, there were 177 full users, 44 partial users and 88 non-users. The mean change in biomarker levels from baseline to the 2-year follow-up was assessed in a primary model that included adjustment for baseline biomarker levels, baseline body mass index and change in body mass index, as well as after adjustment for numerous relevant covariates. No significant overall difference in IL-6 level change was found among full, partial and non-users. However, in severely obese patients (body mass index ≥35), a significant increase in IL-6 levels during the 2-year period was found in partial and non-users, compared to no change in full users. Results were attenuated in a smaller propensity score matched subsample, although similar trends were observed. No differences were found in soluble IL-6 receptor levels between full users and non-users, after adjustment for confounders. In conclusion, among untreated obese sleep apnea patients, IL-6 levels increase substantially during 2 years, while adherence to positive airway pressure treatment may prevent further increases in this inflammatory biomarker. P01 HL094307 NHLBI NIH HHS R01 HL072067 NHLBI NIH HHS Article in Journal/Newspaper Iceland Hirsla - Landspítali University Hospital research archive Journal of Sleep Research 24 2 148 159 |
institution |
Open Polar |
collection |
Hirsla - Landspítali University Hospital research archive |
op_collection_id |
ftlandspitaliuni |
language |
English |
topic |
Inflammation Obesity Sleep Apnea Obstructive Cytokine Receptor gp130 Biological Markers/analysis Body Mass Index Continuous Positive Airway Pressure/utilization* Female Follow-Up Studies Humans Iceland Interleukin-6/analysis Interleukin-6/metabolism* Male Middle Aged Patient Compliance/statistics & numerical data Receptors Interleukin-6/metabolism |
spellingShingle |
Inflammation Obesity Sleep Apnea Obstructive Cytokine Receptor gp130 Biological Markers/analysis Body Mass Index Continuous Positive Airway Pressure/utilization* Female Follow-Up Studies Humans Iceland Interleukin-6/analysis Interleukin-6/metabolism* Male Middle Aged Patient Compliance/statistics & numerical data Receptors Interleukin-6/metabolism Arnardottir, Erna S Lim, Diane C Keenan, Brendan T Maislin, Greg Benediktsdottir, Bryndis Juliusson, Sigurdur Pack, Allan I Gislason, Thorarinn Effects of obesity on the association between long-term sleep apnea treatment and changes in interleukin-6 levels: the Icelandic Sleep Apnea Cohort. |
topic_facet |
Inflammation Obesity Sleep Apnea Obstructive Cytokine Receptor gp130 Biological Markers/analysis Body Mass Index Continuous Positive Airway Pressure/utilization* Female Follow-Up Studies Humans Iceland Interleukin-6/analysis Interleukin-6/metabolism* Male Middle Aged Patient Compliance/statistics & numerical data Receptors Interleukin-6/metabolism |
description |
To access publisher's full text version of this article click on the hyperlink at the bottom of the page The aim of this study was to evaluate changes in interleukin (IL)-6 and soluble IL-6 receptor levels in obstructive sleep apnea patients and assess the role of positive airway pressure treatment and obesity on these changes. A total of 309 newly diagnosed subjects with sleep apnea from the Icelandic Sleep Apnea Cohort were referred for treatment and reassessed at a 2-year follow-up. Full treatment was defined objectively as use ≥4 h day(-1) and ≥20 days month(-1) . At the 2-year follow-up, there were 177 full users, 44 partial users and 88 non-users. The mean change in biomarker levels from baseline to the 2-year follow-up was assessed in a primary model that included adjustment for baseline biomarker levels, baseline body mass index and change in body mass index, as well as after adjustment for numerous relevant covariates. No significant overall difference in IL-6 level change was found among full, partial and non-users. However, in severely obese patients (body mass index ≥35), a significant increase in IL-6 levels during the 2-year period was found in partial and non-users, compared to no change in full users. Results were attenuated in a smaller propensity score matched subsample, although similar trends were observed. No differences were found in soluble IL-6 receptor levels between full users and non-users, after adjustment for confounders. In conclusion, among untreated obese sleep apnea patients, IL-6 levels increase substantially during 2 years, while adherence to positive airway pressure treatment may prevent further increases in this inflammatory biomarker. P01 HL094307 NHLBI NIH HHS R01 HL072067 NHLBI NIH HHS |
author2 |
Department of Respiratory Medicine and Sleep, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland; Faculty of Medicine, University of Iceland, Reykjavik, Iceland; Center for Sleep and Circadian Neurobiology, Division of Sleep Medicine/Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. |
format |
Article in Journal/Newspaper |
author |
Arnardottir, Erna S Lim, Diane C Keenan, Brendan T Maislin, Greg Benediktsdottir, Bryndis Juliusson, Sigurdur Pack, Allan I Gislason, Thorarinn |
author_facet |
Arnardottir, Erna S Lim, Diane C Keenan, Brendan T Maislin, Greg Benediktsdottir, Bryndis Juliusson, Sigurdur Pack, Allan I Gislason, Thorarinn |
author_sort |
Arnardottir, Erna S |
title |
Effects of obesity on the association between long-term sleep apnea treatment and changes in interleukin-6 levels: the Icelandic Sleep Apnea Cohort. |
title_short |
Effects of obesity on the association between long-term sleep apnea treatment and changes in interleukin-6 levels: the Icelandic Sleep Apnea Cohort. |
title_full |
Effects of obesity on the association between long-term sleep apnea treatment and changes in interleukin-6 levels: the Icelandic Sleep Apnea Cohort. |
title_fullStr |
Effects of obesity on the association between long-term sleep apnea treatment and changes in interleukin-6 levels: the Icelandic Sleep Apnea Cohort. |
title_full_unstemmed |
Effects of obesity on the association between long-term sleep apnea treatment and changes in interleukin-6 levels: the Icelandic Sleep Apnea Cohort. |
title_sort |
effects of obesity on the association between long-term sleep apnea treatment and changes in interleukin-6 levels: the icelandic sleep apnea cohort. |
publisher |
Blackwell Scientific Publications |
publishDate |
2015 |
url |
http://hdl.handle.net/2336/346790 https://doi.org/10.1111/jsr.12252 |
genre |
Iceland |
genre_facet |
Iceland |
op_relation |
http://dx.doi.org/10.1111/jsr.12252 http://onlinelibrary.wiley.com/doi/10.1111/jsr.12252/epdf J Sleep Res 2015, 24 (2):148-59 1365-2869 25359691 doi:10.1111/jsr.12252 http://hdl.handle.net/2336/346790 Journal of sleep research |
op_rights |
Archived with thanks to Journal of sleep research National Consortium - Landsaðgangur |
op_doi |
https://doi.org/10.1111/jsr.12252 |
container_title |
Journal of Sleep Research |
container_volume |
24 |
container_issue |
2 |
container_start_page |
148 |
op_container_end_page |
159 |
_version_ |
1766043192837275648 |